| Domain | Curated finding | Suggested ontology/identifier | Evidence level/limitations |
|---|---|---|---|
| Disease entity | Ultra-rare Mendelian neurodevelopmental syndrome recorded as **intellectual disability, anterior maxillary protrusion, and strabismus** | **MONDO:0013353** | Disease identity supported by curated disease-target mapping; literature base is very small and largely historical (pqac-00000000) |
| Source type | Evidence is derived from **aggregated disease-level curation** linked to a very small number of published human families/cases, not from EHR-scale cohorts | MONDO disease record; Open Targets disease-target association | No modern registry, cohort, or natural-history dataset identified (pqac-00000000) |
| Causal gene | The disorder is linked to **SOBP** (*sine oculis binding protein homolog*) | **SOBP**; **ENSG00000112320** | Unique disease-target association found; foundational literature cited in the disease-target resource includes PMIDs **17618476** and **21035105** (pqac-00000000) |
| Inheritance | **Autosomal recessive** disorder caused by **germline** biallelic pathogenic variation in **SOBP** | Suggested term: autosomal recessive inheritance | Direct disease-specific human evidence is sparse; inheritance assignment is based on curated disease-gene linkage and legacy syndrome descriptions (pqac-00000000) |
| Variant/mechanism class | Human syndrome is associated with **loss/truncation** of SOBP; model and review evidence indicate **truncated proteins lacking the C-terminal nuclear localization signal** can impair nuclear localization | Suggested terms: loss of function; protein truncation; impaired nuclear localization | Strong mechanistic support from model/review synthesis, but detailed human variant spectrum is not recoverable from the presently available full text in this tool session (pqac-00000005, pqac-00000006, pqac-00000007) |
| Core phenotype: cognition | **Intellectual disability / developmental delay** is a core feature | Suggested HPO terms: Intellectual disability; Global developmental delay | Core phenotype consistently referenced in disease naming and syndrome summaries; precise severity/frequency not established from current accessible primary text (pqac-00000000, pqac-00000005) |
| Core phenotype: craniofacial | **Anterior maxillary protrusion** and broader **craniofacial dysmorphism** are defining features | Suggested HPO term: Anterior maxillary protrusion; suggested broader term: Abnormal facial shape | Syndrome-defining feature in the disease label; recent review-level model synthesis notes craniofacial abnormalities in all affected individuals discussed there, but exact human denominator is limited (pqac-00000000, pqac-00000005) |
| Core phenotype: ocular | **Strabismus** is a defining ocular phenotype | Suggested HPO term: Strabismus | Ocular association is part of the disease name and included in a 2025 review of strabismus across genetic syndromes; detailed subtype/frequency remains unclear from currently accessible text (pqac-00000000, pqac-00000003) |
| Additional phenotype | **Possible hearing loss** may occur in some affected individuals | Suggested HPO term: Hearing impairment | Evidence appears limited/inconsistent; a recent review excerpt states hearing loss occurred in **one patient** in a human MRAMS-context summary, so this should be treated as possible rather than universal (pqac-00000005) |
| Molecular function | SOBP encodes a **nuclear zinc-finger protein** involved in developmental transcriptional regulation | Suggested GO terms: nucleus; DNA-binding/transcriptional regulation-related functions | Directly supported in mouse work showing nuclear localization and developmental roles; extrapolation to human neurocognitive phenotype remains inferential (pqac-00000006, pqac-00000007) |
| Pathophysiology | Current working model: **germline truncating/loss-of-function SOBP variants → impaired nuclear localization / altered transcriptional cofactor activity → abnormal craniofacial, sensory, and neurodevelopmental patterning → syndromic phenotype** | Suggested GO/process names: craniofacial development; sensory organ development; regulation of transcription | Causal chain is biologically plausible and supported by animal/cellular evidence, but not fully demonstrated in human patient tissues (pqac-00000005, pqac-00000006, pqac-00000007, pqac-00000008) |
| Pathway/cofactor biology | Xenopus/review evidence indicates **SOBP binds Six1 directly** and also **binds Eya1**, modulating Six1-dependent transcription and affecting craniofacial/otic development | Suggested pathway names: Six1/Eya1 developmental transcriptional network | Mechanistic evidence is preclinical and should not be overinterpreted as fully established human disease mechanism (pqac-00000005) |
| Anatomy affected | Primary systems implicated: **central nervous system/development**, **craniofacial structures (maxilla/facial skeleton/cartilage)**, **ocular alignment pathways**, and possibly **inner ear/auditory system** | Suggested anatomy terms: maxilla; eye; brain; inner ear | Human anatomic resolution is limited; several assignments rely partly on model data and syndrome naming (pqac-00000000, pqac-00000005, pqac-00000007, pqac-00000008) |
| Mouse model | **Jxc1/Sobp** mutant mice show **deafness**, **shortened cochlea**, disrupted **organ of Corti patterning**, supernumerary/ectopic hair cells, and mutant protein mislocalization from nucleus toward cytoplasm | Suggested model identifier: mouse *Sobp* / *Jxc1* mutant | Strong primary experimental evidence for ear-development roles; does **not** directly model the full human intellectual-disability/strabismus phenotype (pqac-00000006, pqac-00000007, pqac-00000008) |
| Xenopus model | **sobp** knockdown disrupts **otic vesicle** and **craniofacial cartilage** development; expression overlaps Six1 in neural tube, placodal progenitor epithelium, and otic vesicle | Suggested model: *Xenopus* sobp loss-of-function | Useful for developmental mechanism and tissue specificity; cognitive and ocular alignment phenotypes are not directly modeled (pqac-00000005, pqac-00000001) |
| Diagnostics | Practical diagnosis is currently **genetics-led**, with consideration of **exome/genome sequencing** or neurodevelopmental/intellectual-disability panels that include **SOBP** when phenotype is compatible | Suggested test identifiers: SOBP sequence analysis; WES/WGS | No disease-specific diagnostic guideline, biomarker, or standardized criteria document identified in 2023–2024 sources (pqac-00000000) |
| Biomarkers | **No validated disease-specific biomarkers identified** | None established | No biomarker studies found (pqac-00000000) |
| Epidemiology | **No reliable prevalence or incidence estimates identified** | None established | Too few reported patients/families; no registry or epidemiologic study found (pqac-00000000) |
| Natural history | **No formal natural-history study identified** | None established | Onset is likely developmental/congenital or early childhood based on syndrome features, but longitudinal course data are lacking (pqac-00000000) |
| Prognosis | **Insufficient disease-specific prognosis data**; morbidity likely dominated by neurodevelopmental impairment and treatable sensory/craniofacial manifestations | None established | No survival, life-expectancy, or prognostic biomarker studies located (pqac-00000000) |
| Treatment | **No disease-specific therapy identified**; management is expected to be **supportive and phenotype-directed** (developmental services, ophthalmology/strabismus care, audiology if indicated, craniofacial/dental assessment) | Suggested NCIT intervention names: supportive care; physical therapy; occupational therapy; speech therapy; strabismus surgery | Supportive approach is inferred from standard care for syndromic neurodevelopmental disorders; no SOBP-specific interventional study located (pqac-00000000, pqac-00000003) |
| Clinical trials | **No disease-specific clinical trials identified** | None | Dedicated trial search was negative (pqac-00000000) |
| Prevention/genetic counseling | Because inheritance is **autosomal recessive**, **genetic counseling**, carrier testing in relatives, and reproductive counseling are relevant once familial variants are known | Suggested terms: genetic counseling; carrier testing | General Mendelian best practice; no disease-specific prevention program or screening guideline found (pqac-00000000) |


*Table: This table condenses the currently retrievable disease-knowledge-base facts for intellectual disability, anterior maxillary protrusion, and strabismus. It emphasizes the confirmed SOBP/MONDO linkage, core phenotypes, model-organism mechanism data, and major evidence gaps such as absent epidemiology, biomarkers, trials, and disease-specific therapy.*